<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3860</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.131340</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Platelet-Rich Plasma in the Treatment of Dorsal Wrist Ganglion&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>N</surname><given-names>Prakasam</given-names></name></contrib><contrib contrib-type="author"><name><surname>A</surname><given-names>Vasudevan</given-names></name></contrib><contrib contrib-type="author"><name><surname>R</surname><given-names>Guru Prasad</given-names></name></contrib><contrib contrib-type="author"><name><surname>S.</surname><given-names>Prabakar M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>K</surname><given-names>Senguttuvan</given-names></name></contrib><contrib contrib-type="author"><name><surname>V</surname><given-names>Palani</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>5</day><month>07</month><year>2021</year></pub-date><volume>3)</volume><issue/><fpage>24</fpage><lpage>27</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Ganglions are one of the commonest soft tissue lesions that arise from a joint capsule or tendon sheath. The gold standard treatment for this is excision biopsy. The other options are intra-lesional hyaluronidase injection or triamcinolone injection after aspiration. These techniques have drawbacks. Surgery has a formation of scar which sometimes has a chance of becoming an unsightly hypertrophic scar. Aim: To check the effectiveness of Platelet Rich Plasma (PRP) in dorsal wrist ganglion. Materials and Methods: A case-control study in adherence with the principles of the Declaration of Helsinki was conducted on 60 patients. 20 patients were given intra-lesional hyaluronidase injection after aspiration and 20 patients were given intralesional PRP injection after aspiration and another 20 patients were given triamcinolone injection after aspiration. Results: PRP group had lower recurrence rates compared to the other two groups. The Hyaluronidase group had recurrences and required a repeat injection, it was also noted that the capsule thickened after the treatment in these patients. Triamcinolone group had lower recurrence rates at 1 month follow up but this eventually increased over a 6 monthly follow up, they also required a second injection Conclusion: PRP is easy to obtain, safe and cost-effective in the management of dorsal wrist ganglion. More studies to be conducted in the future in a larger population with a larger observational period to confirm this.&#13;
</p></abstract><kwd-group><kwd> Protein-rich Plasma</kwd><kwd> Platelet Rich Plasma (PRP)</kwd><kwd> Ganglion</kwd><kwd> Hyaluronidase</kwd><kwd> Triamcinolone</kwd></kwd-group></article-meta></front></article>
